3. Umbruch 4.4..2005 - Online Pot

272 Index
sterol 242
striatum 93
stroke 80, 87
stromal cell 201
substantia nigra pars compacta 93
substantia nigra pars reticulata 83
Suncus murinus 187
Suncus 189, 190, 191
superoxide dismutase 84, 100
superoxide 84
Sushruta Samhita 2
symptom relief 245
synergism 158
Synhexyl 234
tail-flick 38
taste avoidance 193, 194
taste reactivity (TR) 193
tau protein 95
terpene 237, 242
terpenoid 236
α-terpineol 16
Tetanus 9
∆ 9 -tetrahyrocannabinol (∆ 9 -THC)
10, 23, 67, 100, 111, 113–115,
117, 118, 184, 187–192, 194,
195, 211, 231, 232, 235, 237,
239, 242–244, 253, 254, 256
tetrahydrocannabivarin (THC-V)
236, 242
Tetranabinex ® 241, 243, 244, 251,
253, 254
therapeutic modulation of the
endocannabinoid system 215
therapeutic window 245, 256, 258
thin-layer chromatography (TLC)
241
tolerability 245, 255, 256, 258
tolerability profile 259
trabecular bone 202
trabecular bone density 203
transcription factor Ikaros 73
transforming growth factor-β 86
transgenic mouse 91
transplant rejection 37
traumatic brain injury 30, 88
traumatic head injury 202
traumatic injury 87, 100
tremor 93, 94, 98, 252
trichome 237
TRPV1 173
tuberculosis 12
tumor necrosis factor-α (TNF-α)
13–15, 83, 85, 86, 93, 95, 97
tumor reduction 13
tyrosine hydroxylase 94
UCM707 80, 157
ulcerative colitis 15
Unani Tibbi 6
URB532 157
URB597 157
urinary disorders 12
uterine receptivity 68
uterus 68
vasoconstriction 87
VDM11 80, 157
Vedas 2
veterinary medicine 11
vijaya 4, 5
virodhamine 17, 26, 234
Visual Analogue Scale (VAS) 251–
253, 255, 257
voltage-sensitive ion channel 83
VR1 receptor 173
WIN-55,212–2 29, 185, 187–189
withdrawal syndrome 209
working memory 112–114, 117
Zend-Avesta 2
Zoroastrianism 2